JULY/AUGUST

Vol 9, No 4 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• understand the current roles for surgery for testicular, bladder, and penile cancer,
  
  
• prescribe immunotherapy for kidney cancer,
  
  
• discuss hormone therapy for prostate cancer,
  
  
• manage “incidental” adrenal masses, and
  
  
• utilize PET scanning in urologic oncology.

This program was planned in accordance with ACCME Essentials.

Release Date: July1, 2002
Expiration Date: July 1, 2003

1. What is the half-life of alpha-fetoprotein (AFP) in the serum?

a. 4 1/2 days
b. 3 days
c. 12 hours
d. 36 hours

 

2. What is the most common life-threatening toxicity of high-dose IL-2 therapy?

a. malaise and mental status changes
b. nausea, vomiting and diarrhea
c. capillary leak syndrome
d. hyperbilirubinemia

 

3. Patients with adrenal incidentalomas who have hypertension should be evaluated for:

a. primary aldosteronism
b. diabetes mellitus
c. chronic glomerulonephritis
d. renal artery stenosis